Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3KC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,774
Award facts
- Contract value 100% obligated
- $15,774.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,774.35 to AmerSourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injections on January 14, 2026, with completion scheduled for January 15, 2026. This firm fixed-price, non-set-aside delivery order will be performed at AmerSourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order executed under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
This delivery order supplies Zepbound (tirzepatide), a diabetes and weight management medication, to support federal military and healthcare system needs. AmerSourceBergen Drug Corp functions as a critical pharmaceutical distributor within the federal supply chain, leveraging its parent company's expansive IDC to fulfill medical commodity requirements across multiple therapeutic domains. The non-competitive nature of this delivery order, executed under an existing IDC, streamlines the procurement process while ensuring continued access to essential pharmaceutical products for Department of Defense healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FG3KC?
SPE2DR26FG3KC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FG3KC worth?
The government has obligated $15,774 on SPE2DR26FG3KC.
Is contract SPE2DR26FG3KC an order under another contract?
Yes. SPE2DR26FG3KC is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3KC competed?
The extent of competition for SPE2DR26FG3KC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award